Biologics Quality Control Testing
Clinical
Diagnostic
Biologics Quality Control Testing
Clinical
Diagnostic
ABOUT US
The NGS-based technology the company developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP level
• The diagnosis of infections (including sepsis) based on blood samples
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
LATEST NEWS
Interview with Colette Côté, Ph.D. : Chief Portfolio Officer and General Manager of PathoQuest’s U.S. subsidiary located in Wayne, PA.
A funny way to meet withMeet Colette Côté the Chief Portfolio Officer and General Manager of PathoQuest US subsidiary and, to understand how NGS solutions that identify adventitious agents using a rapid, animal-free, comprehensive testing approach can accelerate the development timelines of biologics.
4th Annual NGS Seminar – 2021 Digital Edition
This digital event will allow you to exchange with NGS experts around NGS for QC testing of biologics hot topics like the latest result of the exclusive study comparing NGS to animal testing.
Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”
The industry needs to bring safer biologics to patient in a more ethical and time effective. Classical viral safety testing approaches often fail to keep pace with the demands faced with new and innovative biomedicines and they have fallen out of favor considering the 3Rs (replacement, reduction, refinement of animal testing). See the calendar in regards with the presentation of the new comparison study between NGS and in vivo.
Let’s Start Something New
Welcome to PathoQuest!